Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,” the firm’s Nobel Prize-winning CEO Demis Hassabis told a panel at the World Economic Forum in Davos this week. “That’s the plan.” The potential of AI-powered drug discovery is huge. Instead of spending years or even decades testing chemicals by hand, machine learning algorithms can sift through mountains of data to spot patterns and predict which molecules could…This story continues at The Next Web
Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
CES 2025: The new tech we're expecting to see from Samsung, NVIDIA, LG and more in Las Vegas
<p>Time to get into the habit of writing "2025" instead of 2024, and the year may have just begun, but the Engadget team is already working hard for CES 2025. This weekend, many from t [...]
Another CNN streaming service is coming, because that totally worked last time
<p>CNN is laying off more employees and making plans to launch another streaming service, according to a memo from CEO Mark Thompson <a data-i13n="elm:context_link;elmt:doNotAffiliate;cp [...]